LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 68.37 | 27.76 | 1218 | 6879 | 0.1771 | 0.6088 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 70.08 | 27.76 | 155 | 6849 | 0.0226 | 0.2416 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 70.08 | 27.76 | 1074 | 6849 | 0.1568 | 0.5841 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 70.08 | 27.76 | 110 | 6849 | 0.0161 | 0.1892 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 70.08 | 27.76 | 1174 | 6849 | 0.1714 | 0.6019 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 71.78 | 27.76 | 165 | 6893 | 0.0239 | 0.2511 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 71.78 | 27.76 | 1040 | 6893 | 0.1509 | 0.5769 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 71.78 | 27.76 | 128 | 6893 | 0.0186 | 0.2118 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 71.78 | 27.76 | 1358 | 6893 | 0.1970 | 0.6306 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 73.48 | 27.76 | 176 | 6957 | 0.0253 | 0.2608 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 73.48 | 27.76 | 1128 | 6957 | 0.1621 | 0.5918 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 73.48 | 27.76 | 127 | 6957 | 0.0183 | 0.2102 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 73.48 | 27.76 | 1369 | 6957 | 0.1968 | 0.6309 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 75.19 | 27.76 | 195 | 7015 | 0.0278 | 0.2767 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 75.19 | 27.76 | 1057 | 7015 | 0.1507 | 0.5778 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 75.19 | 27.76 | 123 | 7015 | 0.0175 | 0.2050 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 75.19 | 27.76 | 1218 | 7015 | 0.1736 | 0.6061 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 76.89 | 27.76 | 184 | 7025 | 0.0262 | 0.2673 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 76.89 | 27.76 | 1173 | 7025 | 0.1670 | 0.5983 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 76.89 | 27.76 | 130 | 7025 | 0.0185 | 0.2134 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 76.89 | 27.76 | 1220 | 7025 | 0.1737 | 0.6062 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 78.60 | 27.76 | 185 | 7045 | 0.0263 | 0.2680 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 78.60 | 27.76 | 1123 | 7045 | 0.1594 | 0.5892 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 78.60 | 27.76 | 142 | 7045 | 0.0202 | 0.2267 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 78.60 | 27.76 | 1282 | 7045 | 0.1820 | 0.6158 | MN20160318_Q01 | I20 |